Business

Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results After the Close of Markets on Thursday, March 11, 2021

LAKE FOREST, Ill., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release

articleAssertio Holdings, Inc.February 18, 20214/company/assertio-therapeutics-inc/news/assertio-holdings-inc-to-report-fourth-quarter-and-full-year-2020-financial-results-after-the-close-of-markets-on-thursday-march-11-2021
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results After the Close of Markets on Thursday, March 11, 2021

About this update from Assertio Holdings, Inc.

[{"type":"text","content":"LAKE FOREST, Ill., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release fourth quarter and full year 2020 financial results on Thursday, March 11, 2021, after the close of markets. Following the release of its financial results, Assertio’s management will host a conference call beginning at 4:30 p.m. eastern time. Conference Call and Webcast Information Date:Thursday, March 11, 2021Time:4:30 p.m. Eastern TimeDial-in numbers:1-877-550-3745 (domestic) 1-281-973-6277 (international)Replay numbers:1-855-859-2056 (domestic) 1-404-537-3406 (international)Conference number:6285078 The live webcast and replay may be accessed at https://investor.assertiotx.com/. Please connect to the Company’s website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. The replay will be available approximately two hours after the call on Assertio’s investor website. About Assertio Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through business development including licensing, mergers, and acquisitions. To learn more visit www.assertiotx.com. Investor Contact Max [email protected] Forward Looking Statements Statements in this communication that are not historical facts are forward-looking statements that reflect Assertio’s current expectations, assumptions and estimates of future performance and economic conditions. These forward-looking statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to, among other things, future events or the future performance or operations of Assertio. All statements other than historical facts may be forward-looking statements and can be identified by words such as “anticipate,” ‘believe,” “could,” “design,” “estimate,” “expect,” “forecast,” “goal,” “guidance,” “imply,” “intend,” “may,” “objective,” “opportunity,” “outlook,” “plan,” “position,” “po...

More updates from Assertio Holdings, Inc.